Skip to content
OpenCapital
Get started

TG Therapeutics TGTX Non Cash Compensation Selling General And Administrative Expenses

Non Cash Compensation Selling General And Administrative Expenses at other companies

Wynn Resorts logo
Wynn ResortsWYNN
$15.59M-9.9%
Gartner logo
GartnerIT
$487.75M+60.3%
Arrowhead Research logo
Arrowhead ResearchARWR
$32.87M+66.4%
Lowe's Companies logo
Lowe's CompaniesLOW
19.2%-0.2pp
Charles River Laboratories logo
Charles River LaboratoriesCRL
$3.21M+117%
Madison Square Garden Sports logo
Madison Square Garden SportsMSGS
$24.37M+7.7%

Other financials

Income statement

See full
Revenue$204.9M+69.6%
Gross profit$171.4M+62.8%
Operating income$34.8M+304%
Net income$19.8M+291%
EPS (diluted)$0.12+300%

Balance sheet

See full
Cash & equivalents$442.2M+235%
Total debt$753.6M+197%
Total equity$583.1M+146%
Total assets$1.5B+133%

Cash flow

See full
Operating cash flow-$17.9M+37.7%
CapEx$51.0K+104%
Free cash flow-$17.9M+37.6%

Valuation

See full
Market cap$8.15B-14.3%
Enterprise value$8.46B-11.1%
P/E17.6×-225×
P/S11.6×-13.0×

Profitability

See full
Gross margin83.1%-4.4pp
Operating margin21.3%+5.9pp
Net margin66%+55.8pp
FCF margin-6,328.4%+4,773pp

Returns & leverage

See full
Return on equity112.6%+92.9pp
Debt / equity1.3×+0.2×
Current ratio5.8×+1.8×

Where this comes from

Reported directly by TG Therapeutics in its filing.

Tagged under the XBRL concept tgtx:NonCashCompensationSellingGeneralAndAdministrativeExpenses.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's non cash compensation selling general and administrative expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TG Therapeutics's non cash compensation selling general and administrative expenses?
TG Therapeutics (TGTX) reported non cash compensation selling general and administrative expenses of $15.08M in Q1 2026.
How has TG Therapeutics's non cash compensation selling general and administrative expenses changed year-over-year?
TG Therapeutics's non cash compensation selling general and administrative expenses increased by 29.5% year-over-year, from $11.64M to $15.08M.
What is the long-term trend for TG Therapeutics's non cash compensation selling general and administrative expenses?
Over 4 years (2021 to 2025), TG Therapeutics's non cash compensation selling general and administrative expenses has grown at a 6.6% compound annual growth rate (CAGR), from $37.23M to $48.05M.
What does non cash compensation selling general and administrative expenses mean?
The value of stock-based compensation awarded to administrative and sales staff.
How do you interpret non cash compensation selling general and administrative expenses?
Rising levels suggest increased reliance on equity to incentivize non-technical staff, impacting dilution and long-term compensation structures.
How does non cash compensation selling general and administrative expenses compare across companies?
Commonly reported by public companies as part of their broader SG&A expense structure.